Venue: Conference Center Basel, Switzerland

Dates: Monday January 20th - Tuesday January 21st, 2020

Registration: Early bird registration now open here!

Call for Abstracts: Submit your research abstract for selection for a poster session (submit by October 15). Details here.

This conference will enhance your insights of digitalization, machine learning and personalized health in infectious diseases. Most recent breakthroughs and translation into applications to clinics will be shown and discussed. Join the key opinion leaders in these fields and build your network with experts in information technology, machine learning and big data, clinical microbiology, infectious diseases, biomedical research, law and ethics, and more. 

For details please visit the conference website

iCal

Scientific exchange has to be fostered during this difficult period with travel and meeting restrictions. Therefore Personalized Health Technologies 2020 will be a virtual-only conference. The event takes place 29 & 30 June 2020 and is organized by the ETH Zurich Technology Platform NEXUS Personalized Health Technologies.

The next steps in personalized health. This conference brings together experts from multiple disciplines to explore present and future directions in the field of personalized health technologies and translational research. The goal is to tackle challenges in chemical hit identification, lead development, molecular circuit analyses, clinical bioinformatics, and multivariate statistics, as well as their clinical application.
 
From patient samples to molecular read outs. Progress in the laboratory representation of clinical material has enabled novel possibilities for discovery and diagnostics with thus far unrivaled proximity to the patient. Advanced cell systems such as organoids allow for in-depth molecular profiling and functional studies as well as investigation of responses to chemical and therapeutic agents. Combined with high-throughput screening and chemical biology, empirical projects of very large scope have not only become conceivable but also present themselves with feasible turnaround time.
 
Integration of molecular modalities and global knowledge. The continuous development of next-generation sequencing and mass spectrometry measurements allow for high-resolution characterization of biomolecules derived from patient samples or mouse models of disease. While early challenges of storage and compute capacity have largely been addressed, present ones are the integration and combined analysis of multifaceted data, including public online resources.

For more information please visit the website

iCal

October 22nd, 2020 at the Geneva School of Business Administration (HEG/HES-SO)!

The event focuses on all aspects of Research Data Management (RDM). It offers a discussion space to exchange on major challenging technologies and approaches that characterize the RDM practices from the researcher's perspective as well as from the institutional point of view.

EMERGENT APPROACHES FOR OPEN SCIENCE

This year's special focus is the double perspective of Open Science and emerging approaches. The event brings together an interdisciplinary community of researchers, librarians, funders, publishers and policy-makers, providing a critical look at the new developments in RDM practices, standards and technologies.

The agenda will feature keynote presentations, workshops and panel discussions.

CALL FOR PAPERS FOR #SRDD2020

For this edition, we invite you to share your recent studies and innovative initiatives related to RDM. What are today’s solutions? What will the future be like?

Topics of interest include, but are not limited to: emergent technologies in RDM and artificial intelligence, practical, ethical and legal aspects of RDM, research data and Open Science, research data quality assessment, and Data Management Plans (DMPs).

IMPORTANT DATES

• Call for papers opening: December 16, 2019

• Submissions deadline: May 31, 2020

• Conference: October 22, 2020

More information on the website

iCal